Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Labs will become king

<< Previous

Bullboard Posts

Next >>

Comment by NoRiskNoRewardon Apr 13, 2021 7:25pm

224 Views

Post# 32990138

RE:RE:RE:RE:Labs will become king

Yes I realize outstanding shares have doubled. But your number are a bit off. Revenue in 2019 was 130mill and the share price hit $7. The profit margins on that were small due to selling wholesale bulk concentrate.

if we go off there shitty 2020 Q4 and they increase each quarter by 25% all the way to 2022 Q1. That would be roughly 18 million with way higher margins. At which they would be on pace to have $80 mill to $100 mill revenue in 2022.

so yes I do predict $4 by next summer. GLTY!

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China